104 related articles for article (PubMed ID: 15493218)
1. Emerging therapies in anticoagulation.
Ansell JE
Manag Care; 2004 Sep; 13(9 Suppl):8-12. PubMed ID: 15493218
[No Abstract] [Full Text] [Related]
2. Factor Xa is a superior target to factor IIa for antithrombotic therapies.
Büller HR
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():37. PubMed ID: 14730477
[No Abstract] [Full Text] [Related]
3. Why is factor Xa not a better target than factor IIa for therapeutic inhibition of coagulation?
Schulman S
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():33-6. PubMed ID: 14730476
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants--the old and the new.
Ansell J
Dis Mon; 2005; 51(2-3):208-12. PubMed ID: 15900274
[No Abstract] [Full Text] [Related]
5. Long-term anticoagulation: the prospects for alternatives to warfarin.
Ansell J
Semin Vasc Surg; 2005 Sep; 18(3):134-8. PubMed ID: 16168888
[TBL] [Abstract][Full Text] [Related]
6. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Turpie AG
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841
[TBL] [Abstract][Full Text] [Related]
7. [Paradigm change in anticoagulation. Natural substances that are selective factor Xa inhibitors].
Alban S
Pharm Unserer Zeit; 2004; 33(3):190-4. PubMed ID: 15208907
[No Abstract] [Full Text] [Related]
8. Anti-factor Xa levels: when should they be used?
Clem JR
S D Med; 2006 Jun; 59(6):261-2. PubMed ID: 16821477
[No Abstract] [Full Text] [Related]
9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Zikria JC; Ansell J
Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
[TBL] [Abstract][Full Text] [Related]
11. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
Oldgren J; Johnston N; Siegbahn A
Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
[TBL] [Abstract][Full Text] [Related]
12. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
Stief TW
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants.
Khoo CW; Tay KH; Shantsila E; Lip GY
Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
[TBL] [Abstract][Full Text] [Related]
14. Investigation of factor Xa inhibitors containing non-amidine S1 elements.
Franciskovich JB; Masters JJ; Tinsley JM; Craft TJ; Froelich LL; Gifford-Moore DS; Klimkowski VJ; Smallwood JK; Smith GF; Smith T; Towner RR; Weir LC; Wiley MR
Bioorg Med Chem Lett; 2005 Nov; 15(21):4838-41. PubMed ID: 16140530
[TBL] [Abstract][Full Text] [Related]
15. Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
Becker RC; Alexander J; Li YF; Bovill E; Spencer FA; Robertson TL; Kunitada S; Dyke CK; Harrington RA
Thromb Haemost; 2004 Dec; 92(6):1229-31. PubMed ID: 15622616
[No Abstract] [Full Text] [Related]
16. DU-176b, an oral, direct Factor Xa antagonist.
Hylek E
Curr Opin Investig Drugs; 2007 Sep; 8(9):778-83. PubMed ID: 17729190
[TBL] [Abstract][Full Text] [Related]
17. Factor Xa inhibition.
Bramlage P; Pittrow D; Kirch W
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():1-3. PubMed ID: 15701141
[No Abstract] [Full Text] [Related]
18. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Andersen JC
Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
[TBL] [Abstract][Full Text] [Related]
19. [Rivaroxaban: mode of action].
Drouet L
Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
[TBL] [Abstract][Full Text] [Related]
20. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Steffel J; Lüscher TF
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
